Quest Diagnostics Incorporated (0KSX.L)

Healthcare | Medical Equipment Services
Income Statement (Quarterly) 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue 2,816,000,000 2,761,000,000 2,652,000,000 2,621,000,000
Cost of Revenue 1,867,000,000 1,818,000,000 1,789,000,000 1,763,000,000
Gross Profit 949,000,000 943,000,000 863,000,000 858,000,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 501,000,000 486,000,000 476,000,000 466,000,000
Operating Expenses 563,000,000 505,000,000 517,000,000 497,000,000
Operating Income 386,000,000 438,000,000 346,000,000 361,000,000
Interest Expense 69,000,000 69,000,000 72,000,000 72,000,000
Income Before Tax 336,000,000 393,000,000 294,000,000 304,000,000
Income Tax Expense 77,000,000 97,000,000 59,000,000 68,000,000
Net Income 245,000,000 282,000,000 220,000,000 222,000,000
Per Share
EPS 2.18 2.51 1.97 1.98
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-12-31 2023-12-31 2022-12-31
Revenue 9,872,000,000 9,252,000,000 9,883,000,000
Cost of Revenue 6,628,000,000 6,291,000,000 6,536,000,000
Gross Profit 3,244,000,000 2,961,000,000 3,347,000,000
Operating Expenses
R&D Expenses 0 0 0
SG&A Expenses 1,770,000,000 1,615,000,000 1,725,000,000
Operating Expenses 1,898,000,000 1,761,000,000 1,725,000,000
Operating Income 1,346,000,000 1,262,000,000 1,622,000,000
Interest Expense 226,000,000 163,000,000 148,000,000
Income Before Tax 1,194,000,000 1,130,000,000 1,235,000,000
Income Tax Expense 273,000,000 248,000,000 264,000,000
Net Income 871,000,000 854,000,000 942,000,000
Per Share
EPS 7.80 7.59 8.12
EPS Diluted 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-12-31 2023-12-31 2022-12-31
Assets
Cash and Cash Equivalents 549,000,000 686,000,000 315,000,000
Short Term Investments 0 0 0
Net Receivables 1,304,000,000 1,210,000,000 1,195,000,000
Inventory 188,000,000 190,000,000 192,000,000
Total Current Assets 2,392,000,000 2,372,000,000 1,898,000,000
Property Plant Equipment 2,764,000,000 2,418,000,000 2,351,000,000
Goodwill and Intangibles 10,619,000,000 8,899,000,000 8,312,000,000
Total Assets 16,153,000,000 14,022,000,000 12,837,000,000
Liabilities
Account Payables 287,000,000 378,000,000 324,000,000
Short Term Debt 937,000,000 456,000,000 247,000,000
Total Current Liabilities 2,169,000,000 1,815,000,000 1,551,000,000
Long Term Debt 6,150,000,000 4,913,000,000 3,978,000,000
Total Liabilities 9,257,000,000 7,604,000,000 6,830,000,000
Shareholders Equity
Retained Earnings 9,360,000,000 8,825,000,000 8,290,000,000
Total Shareholders Equity 6,778,000,000 6,307,000,000 5,893,000,000
Balance Sheet (Annual) 2024-12-31 2023-12-31 2022-12-31
Assets
Cash and Cash Equivalents 549,000,000 686,000,000 315,000,000
Short Term Investments 0 0 0
Net Receivables 1,304,000,000 1,210,000,000 1,195,000,000
Inventory 188,000,000 190,000,000 192,000,000
Total Current Assets 2,392,000,000 2,372,000,000 1,898,000,000
Property Plant Equipment 2,764,000,000 2,418,000,000 2,351,000,000
Goodwill and Intangibles 10,619,000,000 8,899,000,000 8,312,000,000
Total Assets 16,153,000,000 14,022,000,000 12,837,000,000
Liabilities
Account Payables 287,000,000 378,000,000 324,000,000
Short Term Debt 937,000,000 456,000,000 247,000,000
Total Current Liabilities 2,169,000,000 1,815,000,000 1,551,000,000
Long Term Debt 6,150,000,000 4,913,000,000 3,978,000,000
Total Liabilities 9,257,000,000 7,604,000,000 6,830,000,000
Shareholders Equity
Retained Earnings 9,360,000,000 8,825,000,000 8,290,000,000
Total Shareholders Equity 6,778,000,000 6,307,000,000 5,893,000,000
Cash Flow Statement (Quarterly) 2024-12-31 2023-12-31 2022-12-31
Operating Activities
Net Income 921,000,000 908,000,000 942,000,000
Depreciation & Amortization 493,000,000 439,000,000 437,000,000
Stock Based Compensation 88,000,000 77,000,000 77,000,000
Change in Working Capital -201,000,000 -145,000,000 119,000,000
Operating Cash Flow 1,334,000,000 1,272,000,000 1,718,000,000
Investing Activities
Capital Expenditure -425,000,000 -408,000,000 -404,000,000
Investments -425,000,000 -408,000,000 -404,000,000
Investing Cash Flow -2,548,000,000 -1,061,000,000 -543,000,000
Financing Activities
Debt Repayment 1,543,000,000 748,000,000 -2,000,000
Common Stock Issued/Repurchased -151,000,000 -275,000,000 -1,285,000,000
Dividends Paid -331,000,000 -314,000,000 -305,000,000
Financing Cash Flow 1,084,000,000 160,000,000 -1,732,000,000
Summary
Free Cash Flow 909,000,000 864,000,000 1,314,000,000
Net Change in Cash -137,000,000 371,000,000 -557,000,000
Cash Flow Statement (Annual) 2024-12-31 2023-12-31 2022-12-31
Operating Activities
Net Income 921,000,000 908,000,000 942,000,000
Depreciation & Amortization 493,000,000 439,000,000 437,000,000
Stock Based Compensation 88,000,000 77,000,000 77,000,000
Change in Working Capital -201,000,000 -145,000,000 119,000,000
Operating Cash Flow 1,334,000,000 1,272,000,000 1,718,000,000
Investing Activities
Capital Expenditure -425,000,000 -408,000,000 -404,000,000
Investments -425,000,000 -408,000,000 -404,000,000
Investing Cash Flow -2,548,000,000 -1,061,000,000 -543,000,000
Financing Activities
Debt Repayment 1,543,000,000 748,000,000 -2,000,000
Common Stock Issued/Repurchased -151,000,000 -275,000,000 -1,285,000,000
Dividends Paid -331,000,000 -314,000,000 -305,000,000
Financing Cash Flow 1,084,000,000 160,000,000 -1,732,000,000
Summary
Free Cash Flow 909,000,000 864,000,000 1,314,000,000
Net Change in Cash -137,000,000 371,000,000 -557,000,000